Angiogenesis in the placenta: The role of reactive oxygen species signaling

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Pereira, Robyn D ^a   De Long, Nicole E ^a   Wang, Ruijun C ^a   Yazdi, Fereshteh T ^a   Holloway, Alison C ^a   Raha, Sandeep ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 8; OXYGEN; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR;

ADVERSE OUTCOME; ANGIOGENESIS; DISEASE ASSOCIATION; FETUS OUTCOME; FIRST TRIMESTER PREGNANCY; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL OBESITY; MATERNAL SMOKING; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PLACENTA CIRCULATION; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SECOND TRIMESTER PREGNANCY; SIGNAL TRANSDUCTION; STILLBIRTH; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY; REPRODUCTION; VASCULARIZATION;

FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; OXIDATIVE STRESS; PLACENTA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84929590658     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/814543     Document Type: Review

References (138)

1. A. M. Carter, "Evolution of placental function in mammals: the molecular basis of gas and nutrient transfer, hormone secretion, and immune responses," Physiological Reviews, vol. 92,no. 4, pp. 1543-1576, 2012.
2. J. Saben, F. Lindsey, Y. Zhong et al., "Maternal obesity is associated with a lipotoxic placental environment," Placenta, vol. 35, no. 3, pp. 171-177, 2014.
3. R.Mehendale, J.Hibbard,A. Fazleabas, and R. Leach, "Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke," The American Journal of Obstetrics and Gynecology, vol. 197, no. 4, pp. 363.e1-363.e5, 2007.
4. C. Pfarrer, L. Macara, R. Leiser, and J. Kingdom, "Adaptive angiogenesis in placentas of heavy smokers," The Lancet, vol. 354, no. 9175, p. 303, 1999.
5. A. Khalil, S. Muttukrishna, K. Harrington, and E. Jauniaux, "Effect of antihypertensive therapy with alpha methyldopa on levels of angiogenic factors in pregnancies with hypertensive disorders," PLoS ONE, vol. 3, no. 7,Article ID e2766, 2008.
6. E. K. Hayes, A. Lechowicz, J. J. Petrik et al., "Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature," PLoS ONE, vol. 7, no. 3, Article ID e33370, 2012.
7. E. K. Hayes, D. R. Tessier, M. E. Percival et al., "Trophoblast invasion and blood vessel remodeling are altered in a rat model of lifelong maternal obesity," Reproductive Sciences, vol. 21, no. 5, pp. 648-657, 2014.
8. A. Kawashima, K. Koide,W. Ventura et al., "Effects of maternal smoking on the placental expression of genes related to angiogenesis and apoptosis during the first trimester," PLoS ONE, vol. 9, no. 8, Article ID e106140, 2014.
9. G. Pardi, A.M.Marconi, and I. Cetin, "Placental-fetal interrelationship in IUGR fetuses-a review," Placenta, vol. 23, pp. S136-S141, 2002.
10. L. P. Reynolds and D. A. Redmer, "Utero-placental vascular development and placental function," Journal of Animal Science, vol. 73, no. 6, pp. 1839-1851, 1995.
11. L. P. Reynolds, P. P. Borowicz, K. A. Vonnahme et al., "Animal models of placental angiogenesis," Placenta, vol. 26, no. 10, pp. 689-708, 2005.
12. R. Pijnenborg, J. Anthony, D. A. Davey et al., "Placental bed spiral arteries in the hypertensive disorders of pregnancy," British Journal of Obstetrics and Gynaecology, vol. 98, no. 7, pp. 648-655, 1991.
13. F. Barut, A. Barut, B. D. Gun et al., "Intrauterine growth restriction and placental angiogenesis," Diagnostic Pathology, vol. 5, no. 1, article 24, 2010.
14. J. Jarvenpaa, J.T.Vuoristo, E. R. Savolainen,O.Ukkola, T. Vaskivuo, and M. Ryynanen, "Altered expression of angiogenesisrelated placental genes in pre-eclampsia associated with intrauterine growth restriction," Gynecological Endocrinology, vol. 23, no. 6, pp. 351-355, 2007.
15. L. Myatt, "Role of placenta in preeclampsia," Endocrine, vol. 19, no. 1, pp. 103-111, 2002.
16. A. S. Cerdeira and S. A. Karumanchi, "Angiogenic factors in preeclampsia and related disorders," Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 11, 2012.
17. L.Avagliano,G. P. Bulfamante,A.Morabito, andA.M.Marconi, "Abnormal spiral artery remodelling in the decidual segment during pregnancy: from histology to clinical correlation," Journal of Clinical Pathology, vol. 64, no. 12, pp. 1064-1068, 2011.
18. H. Pinar and M.Carpenter, "Placenta and umbilical cord abnormalities seen with stillbirth," Clinical Obstetrics & Gynecology, vol. 53, no. 3, pp. 656-672, 2010.
19. M. Kovo, L. Schreiber, and J. Bar, "Placental vascular pathology as amechanism of disease in pregnancy complications," Thrombosis Research, vol. 131, supplement 1, pp. S18-S21, 2013.
20. J.Kristensen, M. Vestergaard, K. Wisborg, U. Kesmodel, andN. J. Secher, "Pre-pregnancy weight and the risk of stillbirth and neonatal death," BJOG, vol. 112, no. 4, pp. 403-408, 2005.
21. B.Huppertz, "Vascular development in the placenta," inThePlacenta: From Development to Disease, H. H. Kay, D. M. Nelson, and Y.Wang, Eds., pp. 36-42,Wiley-Blackwell, Singapore, 2011.
22. Y. Wang and S. Zhao, "Vasculogenesis and angiogenesis of human placenta," in Vascular Biology of the Placenta, pp. 31-35, Morgan and Claypool Life Sciences, San Rafael, Calif, USA, 2010.
23. E. Aşn, F. F. Kaymaz, A. N. Çkar, A. Daʇdeviren, and M. S. Beksac? "Vasculogenesis in early human placental villi: an ultrastructural study," Annals of Anatomy, vol. 181, no. 6, pp. 549-554, 1999.
24. L. K. Harris, R. J. Keogh, M. Wareing et al., "Invasive trophoblasts stimulate vascular smooth muscle cell apoptosis by a fas ligand-dependent mechanism," American Journal of Pathology, vol. 169, no. 5, pp. 1863-1874, 2006.
25. M. Zygmunt, F. Herr, K. Munstedt, U. Lang, and O. D. Liang, "Angiogenesis and vasculogenesis in pregnancy," European Journal of Obstetrics &Gynecology and Reproductive Biology, vol. 110, supplement 1, pp. S10-S18, 2003.
26. I. Fridovich, "Superoxide radical and superoxide dismutases," Annual Review of Biochemistry, vol. 64, pp. 97-112, 1995.
27. S. Raha and B. H. Robinson, "Mitochondria, oxygen free radicals, disease and ageing," Trends in Biochemical Sciences, vol. 25, no. 10, pp. 502-508, 2000.
28. G. J. Burton and E. Jauniaux, "Oxidative stress," Best Practice and Research: Clinical Obstetrics and Gynaecology, vol. 25, no. 3, pp. 287-299, 2011.
29. S. Raha and B. H. Robinson, "Metabolic actions of free radicals: walking the tightrope," Heart and Metabolism, vol. 19, pp. 4-10, 2003.
30. G. J. Burton, "Oxygen, the Janus gas; its effects on human placental development and function," Journal of Anatomy, vol. 215, no. 1, pp. 27-35, 2009.
31. Y. Wang and S. W. Walsh, "Placental mitochondria as a source of oxidative stress in pre-eclampsia," Placenta, vol. 19, no. 8, pp. 581-586, 1998.
32. E. Jauniaux,A.L.Watson, J. Hempstock, Y.-P.Bao, J.N. Skepper, and G. J. Burton, "Onset of maternal arterial blood flow and placental oxidative stress: a possible factor in human early pregnancy failure,"The American Journal of Pathology, vol. 157, no. 6, pp. 2111-2122, 2000.
33. L. Myatt and X. Cui, "Oxidative stress in the placenta," Histochemistry and Cell Biology, vol. 122, no. 4, pp. 369-382, 2004.
34. T. M. Mayhew, "Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells," Placenta, vol. 23, no. 10, pp. 742-750, 2002.
35. R. Bassi, M. Kaur, and S. Sharma, "Study of changes in lipid profile, lipid peroxidation and superoxide dismutase during normal pregnancy," Indian Journal of Fundamental and Applied Life Sciences, vol. 1, pp. 249-254, 2011.
36. P. Saikumar, D. Jaya, and M. R. Renuka Devi, "Oxidative stress in pregnancy," ISORJournal of Dental andMedical Sciences, vol. 3, pp. 12-13, 2013.
37. J. G.Gubaljević andA. ɤaušević, "Monitoring changes in serum 8-isoprostane concentrations as possible marker of oxidative stress in pregnancy," Jounal of Health Sciences, vol. 3, pp. 227-231, 2013.
38. V. Toescu, S. L. Nuttall, U. Martin,M. J.Kendall, and F. Dunne, "Oxidative stress and normal pregnancy," Clinical Endocrinology, vol. 57, no. 5, pp. 609-613, 2002.
39. S. B. Patil, M. V. Kodliwadmath, and S. M. Kodliwadmath, "Study of oxidative stress and enzymatic antioxidants in normal pregnancy," Indian Journal of Clinical Biochemistry, vol. 22, no. 1, pp. 135-137, 2007.
40. T.-H. Hung, L.-M. Lo, T.-H. Chiu et al., "A Longitudinal study of oxidative stress and antioxidant status in women with uncomplicated pregnancies throughout gestation," Reproductive Sciences, vol. 17, no. 4, pp. 401-409, 2010.
41. R. L. Andres andM.-C.Day, "Perinatal complications associated with maternal tobacco use," Seminars in Neonatology, vol. 5, no. 3, pp. 231-241, 2000.
42. V.W. Jaddoe, B. O. Verburg, M. A. J. de Ridder et al., "Maternal smoking and fetal growth characteristics in different periods of pregnancy: the Generation R Study," The American Journal of Epidemiology, vol. 165, no. 10, pp. 1207-1215, 2007.
43. A. Castles, E. K. Adams, C. L. Melvin, C. Kelsch, and M. L. Boulton, "Effects of smoking during pregnancy: five metaanalyses," The American Journal of Preventive Medicine, vol. 16, no. 3, pp. 208-215, 1999.
44. E.M.Kho, R.A.North, E.Chan, P. R. Stone, G. A. Dekker, and L. M.McCowan, "Changes in Doppler flow velocity waveforms and fetal size at 20 weeks gestation among cigarette smokers," BJOG, vol. 116, no. 10, pp. 1300-1306, 2009.
45. C. C. Venditti, R. Casselman, M. S. Murphy, S. L. Adamson, J. G. Sled, and G.N. Smith, "Chronic carbon monoxide inhalation during pregnancy augments uterine artery blood flow and uteroplacental vascular growth in mice," American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 305, no. 8, pp. R939-R948, 2013.
46. G. J. Burton, M. E. Palmer, and K. J. Dalton, "Morphometric differences between the placental vasculature of non-smokers, smokers and ex-smokers," British Journal of Obstetrics and Gynaecology, vol. 96, no. 8, pp. 907-915, 1989.
47. W. J. van der Velde, J. H. J. Copius, J. H. Peereboom-Stegeman, P. E. Treffers, and J. James, "Structural changes in the placenta of smoking mothers: a quantitative study," Placenta, vol. 4, no. 3, pp. 231-240, 1983.
48. T. Zdravkovic, O. Genbacev, A. Prakobphol et al., "Nicotine downregulates the l-selectin system that mediates cytotrophoblast emigration from cell columns and attachment to the uterine wall," Reproductive Toxicology, vol. 22, no. 1, pp. 69-76, 2006.
49. A. C. Holloway, A. Salomon, M. J. Soares et al., "Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies," The American Journal of Physiology-Endocrinology and Metabolism, vol. 306, no. 4, pp. E443-E456, 2014.
50. H. Votavova, M. D. Merkerova, K. Fejglova et al., "Transcriptome alterations in maternal and fetal cells induced by tobacco smoke," Placenta, vol. 32, no. 10, pp. 763-770, 2011.
51. E. H. Sidle, R. Casselman, and G. N. Smith, "Effect of cigarette smoke on placental antioxidant enzyme expression," The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 293, no. 2, pp. R754-R758, 2007.
52. E. Sbrana, M. A. Suter, A. R. Abramovici et al., "Maternal tobacco use is associated with increased markers of oxidative stress in the placenta," American Journal of Obstetrics and Gynecology, vol. 205, no. 3, pp. 246.e241-246.e247, 2011.
53. A. Aycicek, M. Varma, K. Ahmet, K. Abdurrahim, and O. Erel, "Maternal active or passive smoking causes oxidative stress in placental tissue," European Journal of Pediatrics, vol. 170, no. 5, pp. 645-651, 2011.
54. I. Rowlands, N. Graves, S. de Jersey, H. D. McIntyre, and L. Callaway, "Obesity in pregnancy: outcomes and economics," Seminars in Fetal and Neonatal Medicine, vol. 15, no. 2, pp. 94-99, 2010.
55. K. Arendas,Q. Qiu, and A. Gruslin, "Obesity in pregnancy: preconceptional to postpartum consequences," Journal of Obstetrics and Gynaecology Canada, vol. 30, no. 6, pp. 477-488, 2008.
56. V. Flenady, L. Koopmans, P.Middleton et al., "Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis," The Lancet, vol. 377, no. 9774, pp. 1331-1340, 2011.
57. T. Becker, M. J. Vermeulen, P. R.Wyatt, C. Meier, and J. G. Ray, "Maternal obesity and the risk of placental vascular disease," Journal of Obstetrics and Gynaecology Canada, vol. 30, no. 12, pp. 1132-1136, 2008.
58. L. Avagliano, A. M. Marconi, S. Romagnoli, and G. P. Bulfamante, "Abnormal spiral arteries modification in stillbirths: the role of maternal prepregnancy body mass index," Journal ofMaternal-Fetal and NeonatalMedicine, vol. 25, no. 12, pp. 2789-2792, 2012.
59. P. K. Lala, "The effects of angiogenic growth factors on extravillous trophoblast invasion and motility," Placenta, vol. 21, no. 5-6, pp. 593-594, 2000.
60. J. C. Cross, M. Hemberger, Y. Lu et al., "Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta,"Molecular and Cellular Endocrinology, vol. 187, no. 1-2, pp. 207-212, 2002.
61. D. A. Redmer, J. S. Luther, J. S. Milne et al., "Fetoplacental growth and vascular development in overnourished adolescent sheep at day 50, 90 and 130 of gestation," Reproduction, vol. 137, no. 4, pp. 749-757, 2009.
62. A. E. Frias, T. K.Morgan, A. E. Evans et al., "Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition," Endocrinology, vol. 152, no. 6, pp. 2456-2464, 2011.
63. Y. Ma, M. J. Zhu, L. Zhang, S. M. Hein, P. W. Nathanielsz, and S. P. Ford, "Maternal obesity and overnutrition alter fetal growth rate and cotyledonary vascularity and angiogenic factor expression in the ewe," The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 299, no. 1, pp. R249-R258, 2010.
64. P. J. Mark, C. Sisala, K. Connor et al., "A maternal high-fat diet in rat pregnancy reduces growth of the fetus and the placental junctional zone, but not placental labyrinth zone growth," Journal of Developmental Origins of Health and Disease, vol. 2, no. 1, pp. 63-70, 2011.
65. C. A. Zera, E. W. Seely, L. E. Wilkins-Haug, K.-H. Lim, S. I. Parry, and T. F. McElrath, "The association of body mass index with serum angiogenic markers in normal and abnormal pregnancies," American Journal of Obstetrics & Gynecology, vol. 211, no. 3, pp. 247.e1-247.e7, 2014.
66. G. J.Burton,D. S. Charnock-Jones, andE. Jauniaux, "Regulation of vascular growth and function in the human placenta," Reproduction, vol. 138, no. 6, pp. 895-902, 2009.
67. M.C.Alanis, E.H. Steadman,Y.Nanevich,D.H. Townsend, and L. H. Goetzl, "Maternal obesity and placental oxidative stress in the first trimester," Journal of Obesity & Weight Loss Therapy, vol. 2, no. 7, article 143, 4 pages, 2012.
68. N.Malti, H.Merzouk, S. A.Merzouk et al., "Oxidative stress and maternal obesity: feto-placental unit interaction," Placenta, vol. 35, no. 6, pp. 411-416, 2014.
69. L. Myatt, W. Kossenjans, R. Sahay, A. Eis, and D. Brockman, "Oxidative stress causes vascular dysfunction in the placenta," Journal of Maternal-Fetal & Neonatal Medicine, vol. 9, no. 1, pp. 79-82, 2000.
70. L. Myatt, "Review: reactive oxygen and nitrogen species and functional adaptation of the placenta," Placenta, vol. 31,pp. S66-S69, 2010.
71. B. Sibai, G. Dekker, and M. Kupferminc, "Pre-eclampsia," Lancet, vol. 365, no. 9461, pp. 785-799, 2005.
72. S. Verlohren, H. Stepan, and R. Dechend, "Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia," Clinical Science, vol. 122, no. 2, pp. 43-52, 2012.
73. S. E. Maynard and S. A. Karumanchi, "Angiogenic factors and preeclampsia," Seminars in Nephrology, vol. 31, no. 1, pp. 33-46, 2011.
74. H.-T. Yuan, D. Haig, and S. Ananth Karumanchi, "Angiogenic factors in the pathogenesis of preeclampsia," Current Topics in Developmental Biology, vol. 71, pp. 297-312, 2005.
75. G. J. Burton, H.-W. Yung, T. Cindrova-Davies, and D. S. Charnock-Jones, "Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia," Placenta, vol. 30, pp. 43-48, 2009.
76. C. Mando, C. De Palma, T. Stampalija et al., "Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia," American Journal of Physiology: Endocrinology and Metabolism, vol. 306, no. 4, pp. E404-E413, 2014.
77. S. Raha, G. E. McEachern, A. T. Myint, and B. H. Robinson, "Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase," Free Radical Biology and Medicine, vol. 29, no. 2, pp. 170-180, 2000.
78. Z. Shi, W. Long, C. Zhao, X. Guo, R. Shen, and H. Ding, "Comparative proteomics analysis suggests that placentalmitochondria are involved in the development of pre-eclampsia," PLoS ONE, vol. 8, no. 5,Article ID e64351, 2013.
79. J. S. Fitzgerald, T. G. Poehlmann, E. Schleussner, and U. R. Markert, "Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3)," Human Reproduction Update, vol. 14, no. 4, pp. 335-344, 2008.
80. L. A. Wilson, A. Gemin, R. Espiritu, and G. Singh, "ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element," The FASEB Journal, vol. 19, no. 14, pp. 2085-2087, 2005.
81. M. Oikawa, M. Abe, H. Kurosawa, W. Hida, K. Shirato, and Y. Sato, "Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-lnducible factor-1," Biochemical and Biophysical Research Communications, vol. 289, no. 1, pp. 39-43, 2001.
82. M. Yasuda, Y. Ohzeki, and S. Shimizu, "Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells," Life Sciences, vol. 64, no. 4, pp. 249-258, 1999.
83. K. Teruyama, M. Abe, T. Nakano et al., "Role of transcription factor Ets-1 in the apoptosis of human vascular endothelial cells," Journal of Cellular Physiology, vol. 188, no. 2, pp. 243-252, 2001.
84. K. Ramirez, K. J. Chandler, C. Spaulding et al., "Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1," Immunity, vol. 36, no. 6, pp. 921-932, 2012.
85. N. Hashiya, N. Jo, M. Aoki et al., "In vivo evidence of angiogenesis induced by transcription factor Ets-1: Ets-1 is located upstream of angiogenesis cascade," Circulation, vol. 109, no. 24, pp. 3035-3041, 2004.
86. G. Elvert, A. Kappel, R. Heidenreich et al., "Cooperative interaction of hypoxia-inducible factor-2α (HIF-2α) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1),"The Journal of Biological Chemistry, vol. 278, no. 9, pp. 7520-7530, 2003.
87. Y. Hasegawa, M. Abe, T. Yamazaki et al., "Transcriptional regulation of human angiopoietin-2 by transcription factor Ets-1," Biochemical and Biophysical Research Communications, vol. 316, no. 1, pp. 52-58, 2004.
88. N. Takai, T. Ueda, H. Narahara, and I. Miyakawa, "Expression of c-Ets1 protein in normal human placenta," Gynecologic and Obstetric Investigation, vol. 61, no. 1, pp. 15-20, 2006.
89. J. Dittmer, "The biology of the Ets1 proto-oncogene," Molecular Cancer, vol. 2, article 29, 2003.
90. B. A. Mercer, A. M. Wallace, C. E. Brinckerhoff, and J. M. D'Armiento, "Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter," The American Journal of Respiratory Cell and Molecular Biology, vol. 40, no. 1, pp. 4-12, 2009.
91. S.Miyazawa-Hoshimoto, K. Takahashi, H. Bujo, N. Hashimoto, and Y. Saito, "Elevated serumvascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects," Diabetologia, vol. 46, no. 11, pp. 1483-1488, 2003.
92. H. Lee, H. J. Kim, Y. J. Lee et al., "Kruppel-like factor KLF8 plays a critical role in adipocyte differentiation," PLoS ONE, vol. 7, no. 12, Article ID e52474, 2012.
93. X. Wang, M. Zheng, G. Liu et al., "Krüppel-like factor 8 induces epithelial to mesenchymal transition and epithelial cell invasion," Cancer Research, vol. 67, no. 15, pp. 7184-7193, 2007.
94. W.-F.Wang, J. Li, L.-T. Du et al., "Krüppel-like factor 8 overexpression is correlated with angiogenesis and poor prognosis in gastric cancer,"World Journal of Gastroenterology, vol. 19, no. 27, pp. 4309-4315, 2013.
95. X.Wang, H. Lu, A.M. Urvalek et al., " KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9," Oncogene, vol. 30, no. 16, pp. 1901-1911, 2011.
96. Z. Yang, B. Bai, X. Luo et al., "Downregulated Krüppel-like factor 8 is involved in decreased trophoblast invasion under hypoxia-reoxygenation conditions," Reproductive Sciences, vol. 21, no. 1, pp. 72-81, 2014.
97. E. Klann, E. D. Roberson, L. T. Knapp, and J. D. Sweatt, "A role for superoxide in protein kinase C activation and induction of long-term potentiation," The Journal of Biological Chemistry, vol. 273, no. 8, pp. 4516-4522, 1998.
98. K. Nadra, L. Quignodon, C. Sardella et al., "PPARγ in placental angiogenesis," Endocrinology, vol. 151, no. 10, pp. 4969-4981, 2010.
99. T. Shono, M. Ono, H. Izumi et al., "Involvement of the transcription factorNF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress," Molecular and Cellular Biology, vol. 16, no. 8, pp. 4231-4239, 1996.
100. B. K. Tan, R. Adya, J. Chen et al., "Metformin decreases angiogenesis via NF-κB and Erk1/2/Erk5 pathways by increasing the antiangiogenic thrombospondin-1," Cardiovascular Research, vol. 83, no. 3, pp. 566-574, 2009.
101. F. R. González-Pacheco, J. J. P. Deudero,M. C. Castellanos et al., "Mechanisms of endothelial response to oxidative aggression: Protective role of autologous VEGF and induction of VEGFR2 by H2O2," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 291, no. 3, pp. H1395-H1401, 2006.
102. R. Bonavia, M. M. Inda, S. Vandenberg et al., "EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway," Oncogene, vol. 31, no. 36, pp. 4054-4066, 2012.
103. A. A. Wani, S. M. Jafarnejad, J. Zhou, and G. Li, "Integrinlinked kinase regulates melanoma angiogenesis by activating NF-B/interleukin-6 signaling pathway," Oncogene, vol. 30, no. 24, pp. 2778-2788, 2011.
104. E. Tartour, H. Pere, B. Maillere et al., "Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy," Cancer and Metastasis Reviews, vol. 30, no. 1, pp. 83-95, 2011.
105. J. E. VaughanandS.W.Walsh, "Activation of NF-κB in placentas of women with preeclampsia," Hypertension in Pregnancy, vol. 31, no. 2, pp. 243-251, 2012.
106. H.M. Zerón, A. P. Flores, A. A. Chávez et al., "Pregnancyweight gain limitation by a supervised nutritional program influences placental NF-κB/IKK complex expression and oxidative stress," Oman Medical Journal, vol. 28, no. 3, pp. 167-172, 2013.
107. C. Lambert, J. Li, K. Jonscher et al., "Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-κB1 DNA binding domain," The Journal of Biological Chemistry, vol. 282, no. 27, pp. 19666-19675, 2007.
108. M. J. Zhu, M. Du, P.W. Nathanielsz, and S. P. Ford, "Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta," Placenta, vol. 31, no. 5, pp. 387-391, 2010.
109. A. K. Jaiswal, "Nrf2 signaling in coordinated activation of antioxidant gene expression,"Free Radical Biology and Medicine, vol. 36, no. 10, pp. 1199-1207, 2004.
110. P.-H. Ducluzeau, M. Priou, M. Weitheimer et al., "Dynamic regulation of mitochondrial network and oxidative functions during 3T3-L1 fat cell differentiation," Journal of Physiology and Biochemistry, vol. 67, no. 3, pp. 285-296, 2011.
111. D. V. Chartoumpekis and T.W. Kensler, "New player on an old field; the keap1/Nrf2 pathway as a target for treatment of type 2 diabetes and metabolic syndrome," Current Diabetes Reviews, vol. 9, no. 2, pp. 137-145, 2013.
112. U. Garbin, A. F. Pasini, C. Stranieri et al., "Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation," PLoS ONE, vol. 4, no. 12, Article ID e8225, 2009.
113. N. Kweider, B. Huppertz, C. J. Wruck et al., "A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia," PLoS ONE, vol. 7, no. 10, Article IDe47055, 2012.
114. E. Jauniaux, L. Poston, and G. J. Burton, "Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution," Human Reproduction Update, vol. 12, no. 6, pp. 747-755, 2006.
115. U. Florczyk, A. Jazwa, M. Maleszewska et al., "Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia," Antioxidants and Redox Signaling, vol. 20, no. 11, pp. 1693-1708, 2014.
116. Z. Zhang, Q. Wang, J. Ma et al., "Reactive oxygen species regulate FSH-induced expression of vascular endothelial growth factor viaNrf2 and HIF1α signaling in human epithelial ovarian cancer," Oncology Reports, vol. 29, no. 4, pp. 1429-1434, 2013.
117. N. Kweider, A. Fragoulis, C. Rosen et al., "Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia," Journal of Biological Chemistry, vol. 286, no. 50, pp. 42863-42872, 2011.
118. L. Li, S. He, J.-M. Sun, and J. R. Davie, "Gene regulation by Sp1 and Sp3," Biochemistry and Cell Biology, vol. 82, no. 4, pp. 460-471, 2004.
119. K. Xie, D. Wei, Q. Shi, and S. Huang, "Constitutive and inducible expression and regulation of vascular endothelial growth factor," Cytokine and Growth Factor Reviews, vol. 15, no. 5, pp. 297-324, 2004.
120. K. J. Higgins, M. Abdelrahim, S. Liu, K. Yoon, and S. Safe, "Regulation of vascular endothelial growth factor receptor-2 expression in pancreatic cancer cells by Sp proteins," Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 292-301, 2006.
121. G. Pagès, "Sp3-mediated VEGF regulation is dependent on phosphorylation by extra-cellular signals regulated kinases (Erk)," Journal of Cellular Physiology, vol. 213, no. 2, pp. 454-463, 2007.
122. P. He, Z. Chen, Q. Sun, Y. Li, H. Gu, and X. Ni, "Reduced expression of 11β-hydroxysteroid dehydrogenase type 2 in preeclamptic placentas is associated with decreased PPARγ but increased PPARα expression," Endocrinology, vol. 155, no. 1, pp. 299-309, 2014.
123. S. Loeffler,B.Fayard, J.Weis, and J.Weissenberger, "Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1," International Journal of Cancer, vol. 115, no. 2, pp. 202-213, 2005.
124. G. Schäfer, T. Cramer, G. Suske,W. Kemmner, B.Wiedenmann, andM. Höcker, "Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1-and Sp3-dependent activation of two proximal GC-rich promoter elements," The Journal of Biological Chemistry, vol. 278, no. 10, pp. 8190-8198, 2003.
125. N. Lahat, H. Bitterman,M. Engelmayer-Goren, D. Rosenzweig, L.Weiss-Cerem, and M.A. Rahat, "Reduced TIMP-2 in hypoxia enhances angiogenesis," The American Journal of Physiology-Cell Physiology, vol. 300, no. 3, pp. C557-C566, 2011.
126. D. H. Platt, M. Bartoli, A. B. El-Remessy et al., "Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3," Free Radical Biology and Medicine, vol. 39, no. 10, pp. 1353-1361, 2005.
127. A.Haghikia, M. Ricke-Hoch, B. Stapel, I.Gorst, and D.Hilfiker-Kleiner, "STAT3, a key regulator of cell-to-cell communication in the heart," Cardiovascular Research, vol. 102, no. 2, pp. 281-289, 2014.
128. J. Bourgeais, V. Gouilleux-Gruart, and F.Gouilleux, "Oxidative metabolism in cancer: A STAT affair?" JAK-STAT, vol. 2, no. 4, Article ID e25764, 2013.
129. Y. Yang, W. Duan, Z. Jin et al., "JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury," Journal of Pineal Research, vol. 55, no. 3, pp. 275-286, 2013.
130. I. H. Ng, Y. Y. Yeap, L. S. Ong, D. A. Jans, and M. A. Bogoyevitch, "Oxidative stress impairs multiple regulatory events to drive persistent cytokine-stimulated STAT3 phosphorylation," Biochimica et Biophysica Acta:Molecular Cell Research, vol. 1843, no. 3, pp. 483-494, 2014.
131. S. Busch, S. J. Renaud, E. Schleussner, C. H. Graham, and U. R. Markert, "mTOR mediates human trophoblast invasion through regulation of matrix-remodeling enzymes and is associated with serine phosphorylation of STAT3," Experimental Cell Research, vol. 315, no. 10, pp. 1724-1733, 2009.
132. R.-J. Chen, Y.-S. Ho, H.-R. Guo, and Y.-J. Wang, "Long-term nicotine exposure-induced chemoresistance is mediated by activation of Stat3 and downregulation of ERK1/2 via nAChR and beta-adrenoceptors in human bladder cancer cells," Toxicological Sciences, vol. 115, no. 1, pp. 118-130, 2010.
133. X. Liu, "STAT3 activation inhibits human bronchial epithelial cell apoptosis in response to cigarette smoke exposure," Biochemical and Biophysical ResearchCommunications, vol. 353, no. 1, pp. 121-126, 2007.
134. R.-H. Shih, I.-T. Lee, H.-L. Hsieh, Y. R. Kou, and C.-M. Yang, "Cigarette smoke extract induces HO-1 expression in mouse cerebral vascular endothelial cells: involvement of c-Src/NADPH oxidase/PDGFR/JAK2/STAT3 pathway," Journal of Cellular Physiology, vol. 225, no. 3, pp. 741-750, 2010.
135. I. L. Aye, S. Lager,V. I. Ramirez et al., "Increasingmaternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways," Biology of Reproduction, vol. 90, no. 6, article 129, 2014.
136. J. C. Challier, S. Basu, T. Bintein et al., "Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta," Placenta, vol. 29, no. 3, pp. 274-281, 2008.
137. M.Weber, C. Kuhn, S. Schulz et al., "Expression of signal transducer and activator of transcription 3 (STAT3) and its activated forms is negatively altered in trophoblast and decidual stroma cells derived from preeclampsia placentae," Histopathology, vol. 60, no. 4, pp. 657-662, 2012.
138. N. Alfaidy, S. Chauvet, S. Donadio-Andrei et al., "Prion protein expression and functional importance in developmental angiogenesis: role in oxidative stress and copper homeostasis," Antioxidants & Redox Signaling, vol. 18, no. 4, pp. 400-411, 2013.